LANA is closely associated with various types of cancers, most notably Kaposi's sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman disease (MCD). These cancers are primarily observed in individuals with compromised immune systems, such as those with HIV/AIDS. The expression of LANA in these malignancies is a hallmark of KSHV infection and is used as a diagnostic marker.
